Vialettes B, Mercier P, De Micco P, Lassmann V, Vague P
Diabete Metab. 1987 Feb;13(1):12-5.
Non HLA antilymphocyte antibodies have been detected in numerous auto-immune illnesses and notably in type I (insulin dependent) diabetes. In order to ascertain their role in this illness, the actual frequency of this phenomenon has been estimated. The privileged cellular target has been determined. Finally correlations with the other immunogenetic markers of diabetes have been investigated. Non HLA antilymphocyte antibodies are frequent, above all at the beginning of the illness (32.4% before 6 months, 10% after 5 years). The cellular target is mainly composed of B lymphocytes. B lymphocyte enrichment of cellular suspensions leads to better method sensitivity (70.3% positive reactions at the beginning of the illness). No correlation was found with presence of anti islet cell antibodies or anti coxsackie B virus antibodies (IgM). Association with the HLA DR3 phenotype is relatively frequent but does not attain statistical significance.
在众多自身免疫性疾病中,尤其是在I型(胰岛素依赖型)糖尿病中,已检测到非HLA抗淋巴细胞抗体。为了确定它们在这种疾病中的作用,已对这一现象的实际发生率进行了估计。已确定了主要的细胞靶点。最后,研究了与糖尿病其他免疫遗传标志物的相关性。非HLA抗淋巴细胞抗体很常见,尤其是在疾病初期(6个月前为32.4%,5年后为10%)。细胞靶点主要由B淋巴细胞组成。细胞悬液中B淋巴细胞富集可提高方法的敏感性(疾病初期阳性反应率为70.3%)。未发现与抗胰岛细胞抗体或抗柯萨奇B病毒抗体(IgM)的存在有相关性。与HLA DR3表型的关联相对常见,但未达到统计学意义。